Rival perspectives in health technology assessment and other economic evaluations for investing in global and national health. Who decides? Who pays?
File version
Version of Record (VoR)
Author(s)
Chalkidou, Kalipso
Teerawattananon, Yot
Santatiwongchai, Benjarin
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
Size
File type(s)
Location
Abstract
There seems to be a general agreement amongst practitioners of economic evaluations, including Health Technology Assessment, that the explicit statement of a perspective is a necessary element in designing and reporting research. Moreover, there seems also to be a general presumption that the ideal perspective is "societal". In this paper we endorse the first principle but dissent from the second. A review of recommended perspectives is presented. The societal perspective is frequently not the one recommended. The societal perspective is shown to be less comprehensive than is commonly supposed, is inappropriate in many contexts and, in any case, is in general not a perspective to be determined independently of the context of a decision problem. Moreover, the selection of a perspective, societal or otherwise, is not the prerogative of analysts.
Journal Title
F1000Res
Conference Title
Book Title
Edition
Volume
7
Issue
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
© 2018 Culyer A et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Item Access Status
Note
Access the data
Related item(s)
Subject
Biochemistry and cell biology
Clinical sciences
Oncology and carcinogenesis
Health services and systems
Public health
Applied economics
CEA
HTA
patients’ preferences.
perspective
reference case
Persistent link to this record
Citation
Culyer, A; Chalkidou, K; Teerawattananon, Y; Santatiwongchai, B, Rival perspectives in health technology assessment and other economic evaluations for investing in global and national health. Who decides? Who pays?, F1000Res, 2018, 7, pp. 72:1-72:19